According to Lannett Company's latest financial reports the company's current EPS (TTM) is -$25.28. In 2022 the company made an earnings per share (EPS) of -$18.89 an increase over its 2021 EPS that were of -$29.00.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$25.28 | 33.83% |
2022 | -$18.89 | -34.86% |
2021 | -$29.00 | 39.16% |
2020 | -$20.84 | 4636.36% |
2019 | -$0.44 | -98.49% |
2018 | -$29.12 | -655.73% |
2017 | $5.24 | -307.94% |
2016 | -$2.52 | -119.5% |
2015 | $12.92 | -9.27% |
2014 | $14.24 | |
2012 | $1.24 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $14.09 | -155.72% | ๐บ๐ธ USA |
Novartis NVS | $3.74 | -114.79% | ๐จ๐ญ Switzerland |
Pfizer PFE | $1.86 | -107.36% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $2.97 | -111.76% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $3.50 | -113.85% | ๐ฌ๐ง UK |